Table II.
Multivariate model exploring risk predictors for BRONJ among patients with cancer treated with BPs (n = 197)
| Predictor | Odds ratio | 95% CI | Value of p |
|---|---|---|---|
| Sex | 1.0909 | 0.5229; 2.2761 | 0.81 |
| Age | 1.0427 | 1.0058; 1.0809 | 0.0231 |
| Oncologic diagnosis | 1.3735 | 0.9674; 1.9501 | 0.08 |
| Duration of the oncologic disease | 1.0032 | 0.9979; 1.0086 | 0.242 |
| Treatment with zoledronate vs. pamidronate | 4.5951 | 1.5939; 7.2250 | < 0.001 |
| Number of given doses | 1.0172 | 1.0018; 1.0328 | 0.023 |
| Oral surgery | 44.433 | 17.366; 113.68 | < 0.001 |
1
Statistical significance is printed in boldface.